# Symrise AG account plan

> Symrise is a German supplier of fragrances, flavors, cosmetic ingredients and pet food ingredients: EUR 4,929 million 2025 sales, 12,745 employees.

## At a glance

Symrise AG, headquartered in Holzminden, Germany, supplies fragrances, flavors, cosmetic active ingredients and functional ingredients to makers of perfumes, cosmetics, food and beverages, pharmaceuticals, dietary supplements and pet food. It sells around 35,000 products based on approximately 9,000 raw materials to more than 6,000 customers in more than 150 countries, and holds around 11 % of the EUR 46.8 billion traditional fragrance, flavor and cosmetic ingredients market. FY2025 sales were EUR 4,929 million (-1.4 % reported, +2.8 % organic), with adjusted EBITDA of EUR 1,081 million (21.9 % margin) and adjusted net income of EUR 513 million. It had 12,745 employees at the end of 2025 and is listed in the DAX, with about 95 % of shares in free float. Dr. Jean-Yves Parisot is CEO.

## Business units

- **Taste, Nutrition & Health** (EUR 3,028 million 2025 sales, about 61 % of group sales): Flavors, natural ingredients and taste solutions for food and beverage makers (Beverages, Sweet, Savory, Naturals) and palatability, nutrition and food-protection solutions for pet food manufacturers. Adjusted EBITDA margin was 23.8 % in 2025; H1 2026 sales were EUR 1,530 million with 3.2 % organic growth, driven by Food & Beverage while Pet Food was flat. Led by Walter Ribeiro.
- **Scent & Care** (EUR 1,901 million 2025 sales, about 39 % of group sales): Fragrance (Fine Fragrances, Consumer Fragrances, Oral Care), Aroma Molecules (menthols and fragrance ingredients) and, from January 1, 2026, the new Care & Wellness division combining cosmetic ingredients, health actives and probiotics, expected above EUR 500 million in 2026 sales. H1 2026 sales were EUR 1,009 million with flat organic growth and a margin of 17.7 %. Led by Michael Friede since December 1, 2025.

## Strategic priorities

- **ONE SYM Transformation**: The execution programme of the ONE Symrise strategy delivered around EUR 50 million of structural savings in 2025 after EUR 50 million in 2024; it is now in Phase 2, with 2026 savings larger but reinvested.
- **From efficiency to effectiveness**: 2026 focus areas are commercial excellence, differentiated innovation, scale benefits across supply chain and procurement, and digitalization including AI.
- **2028 mid-term targets**: Organic sales growth of 5 % to 7 % a year, EBITDA margin of 21 % to 23 % and business free cash flow above 14 % of sales.
- **Portfolio focus**: Exit lower-margin, capital-intensive businesses (Aqua Feed exited, terpene business for sale) and grow in Food & Beverages, Fragrances, Pet Food and Care & Wellness.
- **Sustainability ambitions**: Net-zero Scope 1-3 by 2040 on a 2025 base year and a living wage for all direct employees by 2030.

## Latest results

In H1 2026 sales were EUR 2,539 million, -0.6 % reported and +2.0 % organic, and adjusted EBITDA fell 1.9 % to EUR 553 million, a 21.8 % margin, as ONE SYM investments and Middle East-related material and logistics costs offset efficiency gains. Organic growth went from a slight Q1 decline to 4.5 % in Q2, led by North America (+9.6 %) and Asia Pacific (+12.3 %) on key account wins. Adjusted business free cash flow rose to EUR 347 million, 13.7 % of sales. 2026 guidance of 2 % to 4 % organic growth and a 21.5 % to 22.5 % margin was confirmed, and the CEO expected Q3 organic growth similar to Q2.

## Investments and deals

- **Share buyback**: A first buyback of up to EUR 400 million running to October 31, 2026; EUR 192.2 million had been spent by June 30.
- **Floral Concept acquisition**: Planned acquisition of a premium natural ingredients house for fine fragrance, to join Maison Lautier in Grasse, with signing expected in August 2026.
- **Capacity expansions**: Capex of EUR 214 million in 2025, with expansions in Pet Food, Fragrance, Food & Beverage and Cosmetic Ingredients, including a new Cosmetic Ingredients plant in India and capacity in Grasse, Granada and Monterrey.
- **Data & AI Hub**: A global Data & AI Hub opened in Barcelona on September 8, 2025, alongside a group-wide CRM platform and the SymVision AI platform.
- **Divestments and Probi**: Probi fully acquired in 2025, Aqua Feed exited, and the terpene business in a structured sale expected to conclude in Q3 2026.

## Challenges and risks

- **Weak demand and guidance cuts**: 2025 organic growth guidance was cut twice, from 5-7 % to 2.3-3.3 %, as demand weakened.
- **Middle East costs**: Higher freight, logistics and raw material costs tied to the Middle East cut the H1 2026 Scent & Care margin to 17.7 %.
- **Asian competition in aroma chemicals**: Aroma Molecules faces a structural change from Chinese menthol producers, and Symrise used tactical pricing in menthol and UV filters.
- **Tariffs and raw materials**: US tariffs raise input costs, and climate, harvest and political risks affect natural raw materials such as vanilla.
- **Antitrust investigations**: Investigations since March 2023 into the four largest fragrance and flavor houses; the US DoJ and India's CCI suspended theirs for Symrise in 2026, while the European Commission and SAMR were not reported as suspended.

## What leadership says

> "Now we are pivoting from the efficiency to the effectiveness." — Dr. Jean-Yves Parisot, CEO, Full Year 2025 results conference call, March 4, 2026

> "Our business gained momentum as the year progressed." — Dr. Jean-Yves Parisot, CEO, H1 2026 results conference call, July 30, 2026

> "As the most critical enabler, AI is the area where I am focusing the most for the time being." — Dr. Jean-Yves Parisot, CEO, Symrise Corporate Report 2025, March 4, 2026

> "We are not experiencing a short-term downturn but a profound shift in which being permanently adaptable is becoming a key success factor." — Michael König, Supervisory Board chair, Symrise Corporate Report 2025, March 4, 2026


## Where a supplier can help

- **Procurement and logistics efficiency**: Tied to ONE SYM savings, mostly from sourcing and procurement, and Middle East freight costs: freight, procurement-analytics and supply-chain optimisation providers fit, as the first pan-European road freight tender shows.
- **AI and data platforms**: Tied to the CEO's AI focus, the Barcelona Data & AI Hub and the investment in a data foundation: data engineering, AI and formulation-software vendors are relevant.
- **Commercial excellence tools**: Tied to the commercial excellence priority and the group-wide CRM platform: sales enablement, pricing and key account management solutions support the go-to-market model.
- **Natural raw material sourcing**: Tied to raw material supply risk and the premium naturals push in fine fragrance: traceability, agricultural sourcing and supplier-audit partners help secure vanilla, citrus and floral inputs.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Symrise Corporate Report 2025](https://symrise.com/corporatereport/2025/home/Symrise_Unternehmensbericht_25_EN_interaktiv_geschuetzt.pdf)

Annual report · 2026-03-04

- Symrise is a Holzminden-based global supplier of fragrances, flavors, cosmetic actives and functional ingredients: around 35,000 products from about 9,000 raw materials for more than 6,000 customers in more than 150 countries; 12,745 employees.
- FY2025 sales EUR 4,929 million (-1.4 % reported, +2.8 % organic); adjusted EBITDA EUR 1,081 million, margin 21.9 % (20.7 % in 2024); adjusted net income EUR 513 million; record adjusted business free cash flow of 15.8 % of sales; dividend proposal EUR 1.25.
- Two segments: Taste, Nutrition & Health (EUR 3,028 million sales, 23.8 % adjusted EBITDA margin; Food & Beverage, Pet Food, Probi) and Scent & Care (EUR 1,901 million, 18.9 %; Fragrance, Cosmetic Ingredients, Aroma Molecules).
- Around 11 % share of the EUR 46.8 billion traditional AFF market, third behind Givaudan (17 %) and DSM-Firmenich (15 %) and ahead of IFF (9 %) by the report's estimates; leading positions in mint, vanilla, L-menthol, UV filters and pet food.
- ONE Symrise strategy (Portfolio, Growth, Efficiency) executed through the ONE SYM Transformation: around EUR 50 million structural savings in 2025 after EUR 50 million in 2024, now reinvested in commercial excellence, innovation, scale and AI.
- Portfolio moves: Aqua Feed exited, terpene business held for sale, Probi fully acquired, new Care & Wellness division (cosmetic ingredients, health actives, probiotics) from January 2026, expected above EUR 500 million sales.
- 2025 guidance was cut twice (organic growth from 5-7 % to 2.3-3.3 %) as demand weakened; the margin target was raised and beaten.
- 2026 guidance: organic growth 2 % to 4 %, adjusted EBITDA margin 21.5 % to 22.5 %, business free cash flow above 14 %; 2028 targets of 5 % to 7 % organic CAGR and 21 % to 23 % margin kept.
- Risks: US tariffs, customer consolidation and price pressure, natural raw material supply, Asian competition in aroma chemicals, antitrust investigations of the four big F&F houses, Swedencare and terpene impairments.

### [Symrise Interim Group Report January - June 2026](https://www.symrise.com/investors/financial-results/)

Interim report · 2026-07-30

- H1 2026 sales EUR 2,539 million, +2.0 % organic and -0.6 % reported (FX -2.4 %).
- Adjusted EBITDA EUR 553 million (-1.9 %), margin 21.8 % vs 22.1 %, as ONE SYM investments and Middle East-related material and logistics costs offset efficiency gains; EPS EUR 1.91.
- Taste, Nutrition & Health: +3.2 % organic, EUR 1,530 million, margin 24.5 %; Food & Beverage mid single-digit growth, Pet Food flat.
- Scent & Care: flat organic, EUR 1,009 million, margin down to 17.7 %; Fragrance mid single-digit growth, Fine Fragrances down, the new Care & Wellness division below prior year on sun filter comparables.
- Regions: Asia/Pacific +7.7 % and North America +5.6 % organic; EAME -2.7 %.
- Adjusted business free cash flow EUR 347 million, 13.7 % of sales (9.2 % a year earlier).
- EUR 192.2 million spent on a share buyback of up to EUR 400 million running to October 31, 2026; net debt incl. pensions 2.2x adjusted EBITDA.
- Terpene sale expected to conclude in Q3 2026; US DoJ and India's CCI suspended their antitrust probes of Symrise.
- 2026 guidance (2-4 % organic growth, 21.5-22.5 % margin, more than 14 % free cash flow) and 2028 targets confirmed.

### [Symrise H1 2026 Results Conference Call (transcript)](https://www.roic.ai/quote/SYIEY/transcripts/2026-year/2-quarter)

Executive talk · Jean-Yves Parisot, CEO · 2026-07-30

- Parisot: organic growth went from a slight Q1 decline to 4.5 % in Q2 (volume 5.1 %), led by North America (+9.6 %) and Asia Pacific (+12.3 %) on key account wins; EAME and Latin America were soft on comparables.
- TN&H grew 4.9 % in Q2 with market-leading Food & Beverage; Scent & Care grew 3.8 % on 6.9 % volume and -3.1 % "tactical" pricing in menthol and UV filters.
- CFO Olaf Klinger: H1 margin 21.8 % (-30 bps) from Middle East freight costs, surcharge timing lag and reinvestment; free cash flow up 47 % to EUR 347 million from supplier terms, inventory and capex discipline.
- Planned acquisition of Floral Concept, a premium natural ingredients house for fine fragrance, to join Maison Lautier in Grasse; Terpenes sale expected to conclude in Q3.
- ONE SYM moved into implementation; savings in 2026 are larger than the EUR 50 million of each of the last two years but reinvested, and not yet quantified.
- Pet: wet food is "a new growth driver"; Pet Nutrition price cuts are now tactical and should normalize next year.
- Buyback aiming for EUR 400 million by end of October; Q3 organic growth expected similar to Q2 ("4% to 5%"); 2026 guidance reaffirmed.

### [Symrise Full Year 2025 Results Conference Call (transcript)](https://www.roic.ai/quote/SYIEY/transcripts/2025-year/4-quarter)

Executive talk · Jean-Yves Parisot, CEO · 2026-03-04

- Parisot calls 2025 "a defining year": 2.8 % organic growth, the highest profitability in 10 years (adjusted EBITDA margin up 120 bps) and record free cash flow despite soft demand.
- EUR 50 million of efficiency gains in 2025 against a EUR 40 million target (EUR 100 million over two years, +280 bps of margin), mostly from procurement; "structural improvements, not onetime gains."
- Strategy now pivots "from the efficiency to the effectiveness": commercial excellence, differentiated innovation, scale in procurement and footprint, and AI.
- Care & Wellness (cosmetic ingredients, health actives, probiotics) launched in Scent & Care, expected above EUR 500 million in 2026 in a market growing more than 5 % a year.
- First share buyback (EUR 400 million to October 2026), 16th consecutive dividend rise to EUR 1.25; payout policy 30-50 %; capex 4-5 % of sales mid-term; leverage range 1.5-2.5x.
- Q1 2026 guided down low single digits on tough comparables and Middle East uncertainty; full-year 2026 guidance of 2-4 % organic growth and 21.5-22.5 % margin.
- Aroma Molecules faces a "structural change" from Chinese menthol producers; the Middle East core region is close to 3 % of turnover; energy is about 2.5 % of sales, about 80 % hedged.

### [Interview with Dr Jean-Yves Parisot, CEO of Symrise (Investment Reports)](https://www.investmentreports.co/interview/dr-jean-yves-parisot-1754)

Executive talk · Jean-Yves Parisot, CEO · 2025-04-24

- Parisot describes Symrise as a flavor and fragrance leader that expanded into natural ingredients and health, with six chemical plants giving backward integration in specialty fragrance ingredients and TN&H as an "augmented flavor house".
- Growth drivers: food and beverage, pet food (pet population growing 2 % a year vs 1 % for humans), cosmetics and fragrance, with the Middle East a key area.
- Demand grows fastest in APAC (China, India, Southeast Asia); the US is in "a slight recession" but remains one of the most important markets; Latin America grows steadily.
- The biggest 2025 challenge is "balancing customer needs with innovation" amid tariffs and climate-hit raw materials; innovation guards against being "copied and commoditized".
- Sourcing ethics: audits and ecosystems with farmers in Madagascar (over 7,000 farmers) and India; footprint goals for scopes 1-2 by 2030 and scope 3 by 2045 at the time.
- Technology: reaction chemistry, biotechnology and natural extraction combined; AI tools (Symvision AI, Scenturion, a perfume with IBM's Watson) predict trends and simplify formulas.

## Questions about Symrise AG

### What does Symrise do?

Symrise supplies fragrances, flavors, cosmetic active ingredients and functional ingredients, including pet food ingredients and probiotics, to manufacturers of perfumes, cosmetics, food and beverages and pet food in more than 150 countries.

### What is Symrise's revenue?

FY2025 sales were EUR 4,929 million, with 2.8 % organic growth and an adjusted EBITDA margin of 21.9 %. H1 2026 sales were EUR 2,539 million.

### How many employees does Symrise have?

12,745 employees at the end of 2025, and 12,936 FTE at June 30, 2026.

### Who leads Symrise?

Dr. Jean-Yves Parisot is CEO and Olaf Klinger is CFO; Michael König chairs the Supervisory Board.

### What is Symrise's strategy?

The ONE Symrise strategy rests on Portfolio, Growth and Efficiency, executed through the ONE SYM Transformation, targeting 5 % to 7 % organic growth and a 21 % to 23 % margin by 2028.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
